SUMMARY A case of Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriasis and psoriatic arthropathy is described. This potentially fatal event was probably precipitated by an interaction between methotrexate and concurrent non-steroidal antiinflammatory drugs, resulting in serious potentiation of the effects of methotrexate.
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Low dose methotrexate treatment is often used to control psoriasis or psoriatic arthropathy, or Her condition rapidly improved and with further dose increases (rising to 7-5 mg at two months and 10 mg at three months) her psoriasis resolved completely, the arthritis improved (ESR 24 mm/h, CRP 25 mg/l), and she was able to start work. She continued to take slow release ibuprofen 1200 mg daily, and prednisolone was reduced to 3 mg daily. Monthly full blood counts and tests of liver and renal function remained normal.
Ten months after starting methotrexate treatment mouth ulceration, epistaxis, and pancytopenia were noted, and methotrexate was discontinued. One week later breathlessness and cough developed and within 48 hours she became extremely ill. Examination showed a thin girl, weight 38 kg, height 1-6 m, with a tachypnoea of 44/min, heart rate 165/min, and blood pressure 95/60 mmHg. There were no abnormal breath sounds, no signs of heart failure, and no lymphadenopathy or hepatosplenomegaly. Investigations disclosed: haemoglobin 71 g/l, leucocytes 15.1 x 109/1 (69% neutrophils, 20% lymphocytes, 6% eosinophils, 5% monocytes), platelets 113 x 109/l, normal liver and renal function tests, and CRP 219 mg/I. Chest x ray showed diffuse bilateral interstitial pulmonary infiltration (Fig. 1) 
